The Importance of Prions

1. TellingGC (2011) Transgenic mouse models and prion strains. Top Curr Chem 305: 79–99.

2. AngersRC, KangHE, NapierD, BrowningS, SewardT, et al. (2010) Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328: 1154–1158.

3. CollingeJ, ClarkeAR (2007) A general model of prion strains and their pathogenicity. Science 318: 930–936.

4. LiJ, BrowningS, MahalSP, OelschlegelAM, WeissmannC (2010) Darwinian evolution of prions in cell culture. Science 327: 869–872.

5. BeringueV, HerzogL, JaumainE, ReineF, SibilleP, et al. (2012) Facilitated cross-species transmission of prions in extraneural tissue. Science 335: 472–475.

6. AngersRC, BrowningSR, SewardTS, SigurdsonCJ, MillerMW, et al. (2006) Prions in skeletal muscles of deer with chronic wasting disease. Science 311: 1117.

7. RaceB, Meade-WhiteK, RaceR, ChesebroB (2009) Prion infectivity in fat of deer with chronic wasting disease. J Virol 83: 9608–9610.

8. AngersRC, SewardTS, NapierD, GreenM, HooverE, et al. (2009) Chronic wasting disease prions in elk antler velvet. Emerging Infectious Diseases 15: 696–703.

9. DeleaultNR, HarrisBT, ReesJR, SupattaponeS (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 104: 9741–9746.

10. WangF, WangX, YuanCG, MaJ (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327: 1132–1135.

11. DeleaultNR, PiroJR, WalshDJ, WangF, MaJ, et al. (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 109: 8546–8551.

12. DeleaultNR, WalshDJ, PiroJR, WangF, WangX, et al. (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 109: E1938–E1946.

13. SmirnovasV, BaronGS, OfferdahlDK, RaymondGJ, CaugheyB, et al. (2011) Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol 18: 504–506.

14. GovaertsC, WilleH, PrusinerSB, CohenFE (2004) Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A 101: 8342–8347.

15. DeMarcoML, DaggettV (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A 101: 2293–2298.

16. KangHE, WengCC, SaijoE, SaylorV, BianJ, et al. (2012) Characterization of conformation-dependent prion protein epitopes. J Biol Chem 287 (44) 37219–37232.

17. CallahanMA, XiongL, CaugheyB (2001) Reversibility of scrapie-associated prion protein aggregation. J Biol Chem 276: 28022–28028.

18. SotoC (2012) Transmissible proteins: expanding the prion heresy. Cell 149: 968–977.

19. PrusinerSB (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336: 1511–1513.

20. NazorKE, KuhnF, SewardT, GreenM, ZwaldD, et al. (2005) Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. Embo J 24: 2472–2480.

21. MoralesR, Duran-AniotzC, CastillaJ, EstradaLD, SotoC (2011) De novo induction of amyloid-beta deposition in vivo. Mol Psychiatry 17 (12) 1347–1353.

22. SandbergMK, Al-DoujailyH, SharpsB, ClarkeAR, CollingeJ (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470: 540–542.

23. MallucciG, DickinsonA, LinehanJ, KlohnPC, BrandnerS, et al. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302: 871–874.

24. MorenoJA, RadfordH, PerettiD, SteinertJR, VerityN, et al. (2012) Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485: 507–511.